Guatemalan Antigua (Coffea arabica)

Guatemalan Antigua (Coffea arabica) is a high-altitude coffee cultivar whose green bean extracts are rich in chlorogenic acids, particularly 5-caffeoylquinic acid, which drives its antioxidant and potential wound-healing properties. These chlorogenic acids scavenge free radicals via ABTS inhibition and may modulate inflammatory pathways relevant to tissue repair.

Category: Coffee Cultivars Evidence: 2/10 Tier: Emerging
Guatemalan Antigua (Coffea arabica) — Hermetica Encyclopedia

Origin & History

Guatemalan Antigua is a premium cultivar variant of Coffea arabica grown in high-altitude volcanic regions of Antigua, Guatemala. The green coffee beans are typically harvested and processed through aqueous extraction or solvent methods like dichloromethane, with the unroasted beans containing higher concentrations of chlorogenic acids (0.54-0.97%) compared to roasted forms.

Historical & Cultural Context

While no specific traditional medicine uses for Guatemalan Antigua were identified, Coffea arabica has been consumed globally as a beverage for its stimulant and antioxidant properties. The cultivar represents modern functional beverage applications rather than formal traditional medicine systems.

Health Benefits

• Wound healing acceleration: Animal studies showed 78.20% wound area reduction with topical green coffee extract application (preliminary evidence, PMID: 27965732)
• Antioxidant activity: Green bean extracts demonstrate strong ABTS radical scavenging properties through chlorogenic acid content (in vitro evidence)
• Anti-inflammatory effects: Reduces nitric oxide production up to 63.1% and reactive oxygen species in LPS-stimulated macrophages at 400 μg/mL (in vitro evidence)
• Antiviral potential: Decaffeinated extracts showed H5N1 neuraminidase inhibition with IC50 55.74-75.23 μg/mL (in vitro evidence)
• Enhanced catalase activity: Increases antioxidant enzyme activity during inflammatory responses (animal model evidence)

How It Works

Chlorogenic acids in Guatemalan Antigua green bean extract, principally 5-caffeoylquinic acid, donate hydrogen atoms to neutralize ABTS and DPPH radicals, reducing oxidative stress at the cellular level. Topical application of green coffee extract appears to accelerate wound closure potentially by modulating matrix metalloproteinase activity and promoting fibroblast proliferation, based on animal model data. Caffeine present in the extract additionally inhibits phosphodiesterase enzymes, elevating intracellular cAMP and contributing to anti-inflammatory signaling.

Scientific Research

No human clinical trials specific to Guatemalan Antigua were identified. Evidence is limited to preclinical studies including one rat wound healing model (PMID: 27965732) showing 78.20% wound reduction, and in vitro studies demonstrating neuraminidase inhibition and anti-inflammatory effects in cell cultures.

Clinical Summary

The strongest available evidence for Guatemalan Antigua green coffee extract in wound healing comes from an animal study (PMID: 27965732) demonstrating a 78.20% reduction in wound area following topical green coffee extract application, though no human clinical trials have replicated this outcome. In vitro studies confirm robust ABTS radical scavenging activity attributable to the high chlorogenic acid content characteristic of high-altitude Coffea arabica cultivars like Antigua. No randomized controlled trials in human populations have specifically examined this cultivar for therapeutic endpoints, and evidence remains classified as preliminary. The current body of research supports antioxidant bioactivity but cannot yet establish clinically recommended dosages or confirmed health outcomes in humans.

Nutritional Profile

Guatemalan Antigua green coffee beans (Coffea arabica) contain the following documented compounds and approximate concentrations per 100g dry weight: Chlorogenic acids (CGAs): 6–12g total, primarily 5-caffeoylquinic acid (5-CQA) at approximately 4–8g, with dicaffeoylquinic acids contributing antioxidant load; Caffeine: 1.2–1.5g (typical Arabica range, lower than Robusta); Trigonelline: 0.6–1.3g (precursor to niacin/vitamin B3 upon roasting); Proteins: 10–13g (comprising all essential amino acids, though bioavailability is limited in roasted form); Carbohydrates: 50–55g total, including sucrose 6–9g (largely degraded by roasting), polysaccharides (mannans, arabinogalactans) 35–40g acting as prebiotic fiber; Lipids: 15–17g, rich in diterpenes cafestol and kahweol (approximately 0.5–1.0g combined, bioavailability highest in unfiltered preparations); Fiber: 30–35g total dietary fiber in whole bean; Minerals: Potassium 1,600–1,800mg, Magnesium 180–220mg, Manganese 1.0–2.0mg, Phosphorus 140–160mg, Calcium 120–140mg; Vitamins: Niacin (B3) generated upon roasting from trigonelline degradation (approximately 10–40mg per 100g roasted, highly variable); Riboflavin (B2) trace amounts 0.2mg; Tocopherols (Vitamin E): 40–80mg in lipid fraction; Bioavailability notes: CGAs are moderately bioavailable (approximately 33% absorbed in humans per ileostomy studies); cafestol and kahweol bioavailability is preparation-dependent (espresso and French press deliver significantly more than paper-filtered coffee); Antigua region high-altitude cultivation (1,500–1,700m, volcanic soil) is associated with elevated CGA and sucrose content relative to lower-altitude Arabica, contributing to the cultivar's noted brightness and body; roasting degree substantially reduces CGA content by 50–95% and converts trigonelline to niacin.

Preparation & Dosage

No clinically studied human dosages available. In vitro studies used 55.74-75.23 μg/mL for antiviral effects and up to 400 μg/mL for anti-inflammatory effects. Animal studies applied topical extracts at unspecified concentrations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, vitamin C, resveratrol, quercetin, curcumin

Safety & Interactions

Green coffee extracts from Coffea arabica contain caffeine, which can cause insomnia, tachycardia, anxiety, and elevated blood pressure at high doses, particularly in caffeine-sensitive individuals. Chlorogenic acids may mildly reduce postprandial glucose absorption, creating a potential additive hypoglycemic effect when combined with antidiabetic medications such as metformin or insulin. Topical formulations are generally considered low-risk, but oral high-dose green coffee extract is contraindicated in individuals with uncontrolled hypertension, cardiac arrhythmias, or anxiety disorders. Pregnant and breastfeeding women should limit intake due to caffeine's ability to cross the placental barrier and its association with adverse fetal outcomes above 200 mg caffeine per day.